Huifeng Bio-Pharmaceutical Technology, Inc. Watch

from 8-K 2 pages Acquisition Agreement

from 10-Q 7 pages Settlement Agreement and Release

from 10-Q 2 pages Independent Director Agreement

from 8-K 6 pages Amendment to Secured Convertible Promissory Notes and Warrants

from 8-K 7 pages Exclusive Option Agreement

from 8-K 2 pages Shareholder’s Voting Proxy Agreement

from 8-K 4 pages Shares Pledge Agreement

from 8-K 7 pages Management Entrustment Agreement

from 8-K 1 page Amendment No. 1 to the Convertible Promissory Note Due June 3o, 2005 This Amendment No. 1 (The "Amendment") Hereby Amends as Set Forth Herein That Certain Convertible Promissory Note Issued by Secured Data, Inc., a Nevada Corporation (The "Company"), Originally Due June 30, 2005 (The "Convertible Note") Issued Pursuant to the Agreement and Plan of Reorganization Dated December 20, 2004 Between Northwest Bio-Technic, Inc., a British Virgin Islands Corporation, Its Shareholders and the Company. the Maturity Date of the Convertible Note of June 30, 2005 Is Hereby Extended to December 31, 2005. All Other Terms and Conditions Set Forth in the Convertible Note Shall Remain in Full Force and Effect and Unaffected by This Amendment. in Witness Whereof, the Company Has Caused This Amendment to Be Duly Executed by a Duly Authorized Officer as of This 30th Day of June 2005. Secured Data, Inc. By: /S/ Jing an Wang Name: Jing an Wang Title: Chief Executive Officer

from 8-K/A ~20 pages Material contract

from 8-K ~20 pages Material contract

from 8-K ~20 pages Material contract

from 10QSB ~5 pages Consulting Agreement

from 10QSB ~5 pages Consulting Agreement

from 10QSB ~5 pages Employment Agreement

from 10KSB ~5 pages Material contract

from 10KSB ~5 pages Material contract

from 10KSB ~5 pages Material contract

from 10KSB ~5 pages Material contract

from 8-K ~10 pages Intellectual Property Purchase Agreement